ANGO - Angiodynamics Inc

NYSE * Health Care * Health Care Equipment & Supplies

$10.34

$-0.13 (-1.24%)

About Angiodynamics Inc

AngioDynamics, Inc., a medical technology company, designs, manufactures, and sells medical, surgical, and diagnostic devices for the use in treating peripheral vascular disease, and oncology and surgical settings in the United States and internationally. It offers Auryon Atherectomy system that delivers an optimized wavelength and short pulse width to remove lesions while preserving vessel wall endothelium. The company's thrombus management portfolio includes AlphaVac mechanical thrombectomy system, an emergent mechanical aspiration device that eliminates the need for perfusionist support; thrombolytic catheters that are used to deliver thrombolytic agents, which are drugs to dissolve blood clots in hemodialysis access grafts, arteries, veins, and surgical bypass grafts; and AngioVac venous drainage cannula and extracorporeal circuit for use in extracorporeal circulatory support procedures for periods of up to six hours, as well as with other manufacturers' off-the-shelf pump, filter, and reinfusion cannula facilitate venous drainage. It also offers NanoKnife IRE Ablation System, an alternative to traditional thermal ablation for the surgical ablation of soft tissue; and peripheral products, which includes angiographic catheters, diagnostic and interventional guidewires, and coaxial micro-introducer kits for use in peripheral diagnostic and interventional procedures. In addition, the company provides abscession drainage catheters for multi-purpose/general, nephrostomy, and biliary drainage; micro-access kits offer interventional physicians a smaller introducer system for minimally invasive procedures; VenaCure EVLT system that are used in endovascular laser procedures to treat superficial venous disease; and Solero Microwave Tissue Ablation System includes solero microwave generator and the solero MW applicators. AngioDynamics, Inc. was founded in 1988 and is headquartered in Latham, New York.

ANGO Key Statistics

Market Cap

$432.61M

0

P/B Ratio

2.44

EPS

$-0.76

Revenue Growth

+0.1%

Profit Margin

-0.1%

Employees

675

How ANGO Compares to Peers

ANGO is the smallest among peers, which may offer higher growth potential

P/E Rank

N/A

of 1

Margin Rank

#2

of 2

Growth Rank

#2

of 2

Size Rank

#2

of 2

CompanyP/EGrowthCompare
ANGON/A0%-
AMZN34.70%vs AMZN

Angiodynamics Inc Company Information

Headquarters
New York; U.S.A
Website
www.angiodynamics.com
Sector
Health Care
Industry
Health Care Equipment & Supplies
Data Updated:
Ready to invest in ANGO?

Commission-free trading available. Affiliate links.

ANGO Lician Score

10% confidence
5.0/10
Neutral

ANGO has a Lician Score of 5/10 (Average). Areas of concern: Growth.

value

5.0

growth

3.0

quality

5.0

momentum

5.0

safety

5.0

The Lician Score is a comprehensive 1-10 rating that evaluates ANGOacross five key dimensions: Value (valuation relative to sector),Growth (revenue and earnings trajectory),Quality (profitability and balance sheet strength),Momentum (price trends and analyst sentiment), andSafety (volatility and risk metrics).

ANGO Financial Snowflake

5-axis analysis across key investment dimensions

4.6/10

Neutral

35810Value5.0Growth3.0Quality5.0Momentum5.0Safety5.04.6/10
5.0

Value

3.0

Growth

5.0

Quality

5.0

Momentum

5.0

Safety

Upcoming Events for ANGO